IndiaCOVID-19Ministry of Health and Family WelfareHealth

COVID – 19 Vaccination Update – Day 372

India’s cumulative vaccination coverage crosses 161.81 crore. More than 61 lakh Vaccine doses administered today till 7 pm

India’s COVID-19 vaccination coverage has crossed 161.81 Crore (1,61,81,65,913) today. More than 61 lakh (61,62,171) Vaccine Doseshave been administered till 7 pm today. More than 79 lakh(79,78,438) Precaution Doses for the identified categories of beneficiaries for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10391928
2nd Dose 9816436
Precaution Dose 2697047
FLWs 1st Dose 18390858
2nd Dose 17131830
Precaution Dose 2615336
Age Group 15-18 years 1st Dose 41436237
Age Group 18-44 years 1st Dose 533682347
2nd Dose 386619600
Age Group 45-59 years 1st Dose 198993965
2nd Dose 166043105
Over 60 years 1st Dose 124020921
2nd Dose 103660248
Precaution Dose 2666055
Cumulative 1st dose administered 926916256
Cumulative 2nd dose administered 683271219
Precaution Dose 7978438
Total 1618165913

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 22nd January, 2022 (372ndDay)
HCWs 1st Dose 308
2nd Dose 5529
Precaution Dose 114173
FLWs 1st Dose 376
2nd Dose 11745
Precaution Dose 142797
Age Group 15-18 years 1st Dose 760779
Age Group 18-44 years 1st Dose 989118
2nd Dose 2444484
Age Group 45-59 years 1st Dose 174302
2nd Dose 725735
Over 60 years 1st Dose 115816
2nd Dose 419916
Precaution Dose 257093
Cumulative 1st dose administered 2040699
Cumulative 2nd dose administered 3607409
Precaution Dose 514063
Total 6162171

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker